Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine

Clinical trial NCT06621654 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06621654
Sponsor: CanSino Biologics Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Haemophilus Influenzae Type B Infection

Start date: 2024-11-15
Primary completion: 2026-10-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.